000			01962 a2200529 4500
005			20250516030239.0
264		0	_c20110719
008			201107s 0 0 eng d
022			_a2042-7158
024	7		_a10.1111/j.2042-7158.2010.01238.x _2doi
040			_aNLM _beng _cNLM
100	1		_aZhao, Rui
245	0	0	_aMontelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. _h[electronic resource]
260			_bThe Journal of pharmacy and pharmacology _cApr 2011
300			_a550-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcetates _xadministration & dosage
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aAntipyrine _xanalogs & derivatives
650	0	4	_aAtrophy _xprevention & control
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aBrain Injury, Chronic _xcomplications
650	0	4	_aChromones _xtherapeutic use
650	0	4	_aCyclopropanes
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aEdaravone
650	0	4	_aFree Radical Scavengers _xtherapeutic use
650	0	4	_aInfarction, Middle Cerebral Artery _xdrug therapy
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aLeukotriene Antagonists _xpharmacology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred ICR
650	0	4	_aNerve Degeneration _xdrug therapy
650	0	4	_aQuinolines _xadministration & dosage
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSulfides
700	1		_aShi, Wen-Zhen
700	1		_aZhang, Yong-Mei
700	1		_aFang, San-Hua
700	1		_aWei, Er-Qing
773	0		_tThe Journal of pharmacy and pharmacology _gvol. 63 _gno. 4 _gp. 550-7
856	4	0	_uhttps://doi.org/10.1111/j.2042-7158.2010.01238.x _zAvailable from publisher's website
999			_c20672956 _d20672956